Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2859

PDF: 1015

HTML: 39
Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

28-12-2021

https://doi.org/10.4081/dr.2022.9454

4156

PDF: 693

APPENDIX: 198

HTML: 20
Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

Christa Ky, Brian Swasdibutra, Shaadi Khademi, Sheetal Desai, Vivian Laquer, Sergei A. Grando

16-03-2015

https://doi.org/10.4081/dr.2015.5804

2828

PDF: 1168

HTML: 252
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1853

PDF: 748

HTML: 109
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2668

PDF: 658

HTML: 16
Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus

Serena Bergamo, Margherita Gobbo, Silvia Chimenton, Giorgia D'Angelo, Luca Guarda Nardini, Alessandro Gatti

09-08-2024

https://doi.org/10.4081/dr.2024.10046

2691

PDF: 830

SUPPLEMENTARY MATERIAL: 279

HTML: 153
Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab

19-05-2023

https://doi.org/10.4081/dr.2023.9703

6334

PDF: 971

APPENDIX 1: 167

HTML: 213
Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study

Marinella Tedesco, Barbara Bellei, Lavinia Alei, Monia Di Prete, Carlo Cota, Tiziano Pallara, Antonio Bonadies, Alessandra Latini, Stefania De Fazio, Emilia Migliano

27-11-2024

https://doi.org/10.4081/dr.2024.10079

906

PDF: 538

HTML: 36
LASMIK laser biorevitalization: mechanisms and therapeutic experience

Sergey Vladimirovich Moskvin, Aleksandr Agubechirovich Khadartsev

28-12-2020

https://doi.org/10.4081/dr.2020.8996

1746

PDF: 474

HTML: 42
Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske

e57

13-12-2011

https://doi.org/10.4081/dr.2011.e57

1966

PDF: 747

HTML: 1027
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

25-06-2020

https://doi.org/10.4081/dr.2020.8642

1422

PDF: 776

HTML: 19
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1122

PDF: 592

HTML: 97
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1132

PDF: 648

HTML: 51
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

1093

PDF: 579

SUPPLEMENTARY MATERIAL: 188

HTML: 24
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

19-06-2023

https://doi.org/10.4081/dr.2023.9755

910

PDF: 443

HTML: 25
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1231

PDF: 865

HTML: 50
Vitiligo: What’s old, what’s new

Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli

15-09-2021

https://doi.org/10.4081/dr.2021.9142

2914

PDF: 1195

HTML: 231
Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Pati Aji Achdiat, Stephanie Widjaja, Oki Suwarsa, Reiva Farah Dwiyana, Reti Hindritiani, Endang Sutedja, Hendra Gunawan, Hermin Aminah Usman, Fathia Rianty, Retno Hesty Maharani

30-01-2024

https://doi.org/10.4081/dr.2024.9754

965

PDF: 569

HTML: 39
New and emerging therapies in cutaneous T-cell lymphoma

Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino

02-10-2024

https://doi.org/10.4081/dr.2024.10002

1226

PDF: 691

HTML: 110
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1369

PDF: 642

HTML: 28
Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob

09-01-2025

https://doi.org/10.4081/dr.2025.10105

517

PDF: 327

HTML: 25
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols

François Pélouard, Valérie Chedru-Legros, Catherine Nganoa, Anne Dompmartin, Jean-Matthieu L'Orphelin

15-04-2025

https://doi.org/10.4081/dr.2025.10036

900

PDF: 364

SUPPLEMENTARY MATERIAL: 106

HTML: 14
Inflammatory seborrheic keratosis resolution after hyperbaric oxygen therapy: Case presentation and pathophysiology review

Karin Elman-Shina, Monica Elman, Shai Efrati

18-03-2021

https://doi.org/10.4081/dr.2021.8871

4289

PDF: 802

HTML: 41
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1169

PDF: 576

HTML: 28
A microRNA focus on acne

Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

02-02-2024

https://doi.org/10.4081/dr.2024.9902

1161

PDF: 751

HTML: 73

1 - 25 of 76 items 1 2 3 4 > >>

Search

Search Results

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus

Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study

LASMIK laser biorevitalization: mechanisms and therapeutic experience

Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Vitiligo: What’s old, what’s new

Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

New and emerging therapies in cutaneous T-cell lymphoma

Erythrodermic psoriasis improved by tildrakizumab

Refractory pityriasis rubra pilaris treated with abrocitinib

Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols

Inflammatory seborrheic keratosis resolution after hyperbaric oxygen therapy: Case presentation and pathophysiology review

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

A microRNA focus on acne

authors

reviewers

Categories

indexing

dermatopathology